Factors associated with and impact of open conversion on the outcomes of minimally invasive left lateral sectionectomies: An international multicenter study
Hao Ping Wang(Kaohsiung Chang Gung Memorial Hospital), Mohammad Abu Hilal(Casa di Cura Villa Garda), Arpad Ivanecz(Seoul National University Hospital), Fernando Rotellar(Universidad de Navarra), Luca Aldrighetti(Vita-Salute San Raffaele University), Constantino Fondevila(Hospital Clínic de Barcelona), Kazuteru Monden(Far Eastern Memorial Hospital), Davit L. Aghayan(Oslo University Hospital), Sung Hoon Choi(NorthShore University HealthSystem), Fabrizio Di Benedetto(University of Modena and Reggio Emilia), Jasper P. Sijberden(Fondazione Poliambulanza Istituto Ospedaliero), Adrian Kah Heng Chiow(Changi General Hospital), Andrea Ruzzenente(University of Verona), Alessandro Ferrero, Andrea Belli(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Olivier Scatton(Université Paris-Saclay), Charing C. N. Chong(National University of Singapore), Mikel Gastaca(University of the Basque Country), Santiago López‐Ben(Hospital Universitari de Girona Doctor Josep Trueta), Михаил Ефанов(Singapore General Hospital), Atsushi Sugioka(Fujita Health University), Daniel Cherqui(Assistance Publique – Hôpitaux de Paris), Olivier Soubrane(Institute Mutualiste Montsouris), Tran Cong Duy Long(University of Medicine and Pharmacy at Ho Chi Minh City), James O. Park(University of Washington Medical Center), Federica Cipriani(Vita-Salute San Raffaele University), Alejandro Mejia(Methodist Dallas Medical Center), Iswanto Sucandy(AdventHealth Tampa), Gi Hong Choi(Yonsei University), Andrew G. R. Wu(National University of Singapore), T. Peter Kingham(Memorial Sloan Kettering Cancer Center), Marco V. Marino(Oslo University Hospital), Giovanni Battista Levi Sandri, Robert P. Sutcliffe(University Hospitals Birmingham NHS Foundation Trust), Johann Pratschke(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), David Fuks(Institute Mutualiste Montsouris), Bjørn Edwin(Oslo University Hospital), Rong Liu(Anhui Medical University), Jae Hoon Lee(Ulsan College), Mathieu D’Hondt(AZ Groeninge), Go Wakabayashi(Hakodate Central General Hospital), Ricardo Robles Campos(Hospital Universitario Virgen de la Arrixaca), Chung Ngai Tang(Pamela Youde Nethersole Eastern Hospital), Roberto Troisi(Federico II University Hospital), Chee‐Chien Yong(Kaohsiung Chang Gung Memorial Hospital), Ho‐Seong Han(Seoul National University Bundang Hospital), Xiaoying Wang(Fudan University), Tan To Cheung(University of Hong Kong - Shenzhen Hospital)
Cited by 18
Related Papers
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
|Nature Genetics|2013|709
Surgery for cholangiocarcinoma
|Liver International|2019|338
Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma
|British journal of surgery|2017|255
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study
|The Lancet Diabetes & Endocrinology|2020|247